Mon 25 Mar
|THE VIDEO IS NOW AVAILABLE "ON DEMAND"
Jeremy Richmon: Transoral Robotic Surgery for HPV Associated Oropharyngeal Cancer
The utilization of robotic and endoscopic techniques has become integral in managing oropharyngeal and laryngeal cancers. These approaches have proven to be effective in reducing surgical morbidity and enhancing survival rates compared to conventional open methods.
Time & Location
25 Mar 2024, 04:00
THE VIDEO IS NOW AVAILABLE "ON DEMAND"
About the event
This session “Transoral Robotic Surgery for HPV Associated Oropharyngeal Cancer” presented an in-depth review of the role of transoral robotic surgery (TORS) in the management of HPV-associated oropharyngeal squamous cell carcinoma. With the rising incidence of HPV-positive oropharyngeal cancers globally, there has been increasing interest in minimally invasive surgical options that allow precise tumor removal while preserving function. TORS enables access to tumors in the tonsils, base of tongue and other oropharyngeal subsites through the mouth, avoiding traditional open approaches that require large incisions and bone cuts, and often results in reduced morbidity, shorter hospital stays and improved functional outcomes. The presentation explored how TORS fits into multidisciplinary care pathways, offered insights into surgical indications and technique, and discussed oncologic and functional results in select patients with HPV-related disease — highlighting current evidence and practical considerations for clinicians managing this disease in the modern era.
The Video is Now Available On Demand
SPEAKER: Jeremy D. Richmon, MD, Associate Professor of Otolaryngology–Head and Neck Surgery Harvard Medical School and Director, Head and Neck Robotic Surgery Massachusetts Eye and Ear
ONLINE LIVE EVENT
San Francisco: Monday, March 25, 2024 at 4:00 am
Mexico City: Monday, March 25, 2024 at 5:00 am
New York: Monday, March 25, 2024 at 7:00 am
Rio de Janeiro: Monday, March 25, 2024 at 8:00 am
London: Monday, March 25, 2024 at 11:00 am
Berlin: Monday, March 25, 2024 at 12:00 noon
Johannesburg: Monday, March 25, 2024 at 1:00 pm
Cairo: Monday, March 25, 2024 at 1:00 pm
Dubai: Monday, March 25, 2024 at 3:00 pm
Islamabad: Monday, March 25, 2024 at 4:00 pm
New Delhi: Monday, March 25, 2024 at 4:30 pm
Kuala Lumpur: Monday, March 25, 2024 at 7:00 pm
Taipei: Monday, March 25, 2024 at 7:00 pm
Manila: Monday, March 25, 2024 at 7:00 pm
LANGUAGE: The event language is English. Closed Caption translation and Portuguese/Spanish speaking moderators will be present.
DECLARATION : In accordance with criterion 13 of document UEMS 2023.07.rev “EACCME® Criteria for the Accreditation of Live Educational Events (LEEs)” and the Standard v. Commercial or Promotional Conflict of Interest, published by the American Dental Association Continuing Education Recognition Program (ADA CERP), all surgeON presenters sign a Conflict of Interest form to document all perceived or actual conflicts of interest for the last 3 years, whether due to a financial or other relationship. This document can be viewed at the beginning of the event or on request by emailing info@surgeon-events.org No fee, honorarium or arrangement for re-imbursement of expenses in relation to the this event has been provided to the speaker.